Cytokinetics cytokinetics.com


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1136)

Cytokinetics is dedicated to the discovery, development and commercialization of a novel class of therapeutics resulting from its leadership position in the emerging field of cytoskeletal pharmacology. The cytoskeleton is a complex, dynamic framework that impacts all aspects of cell function including cell division, cell motility, intracellular transport, muscle contractility and regulation of cellular organization. Cytokinetics' R&D efforts aim to address pharmaceutical needs in cancer, cardiov...Show all

Cytokinetics is dedicated to the discovery, development and commercialization of a novel class of therapeutics resulting from its leadership position in the emerging field of cytoskeletal pharmacology. The cytoskeleton is a complex, dynamic framework...Show all

Company (IPO / Went public)

Phone: 650-624-3000

Fax:

280 East Grand Avenue

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cytokinetics $257.1M Jan 23, 2006
See all 31 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cytokinetics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alta PartnersVenture CapitalSan Francisco, California, United StatesUnattributed VC, Series C
CSFBInvestment BankNew York, New York, United StatesUnattributed VC, Series C
Federated InvestorsOtherPIPE
Duke Management CompanySeries B
Federated Equity Funds - Federated Kaufmann FundAsset/Investment ManagementPIPE
See all 18 investors

Competitors

Company Status Description Investors
See all 31 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Heterocyclic compounds and their uses Mar 14, 2014 Apr 24, 2018 Patent
Tetrahydroisoquinoline derivatives Feb 10, 2017 Mar 13, 2018 Patent
Amino-pyrimidine skeletal muscle modulators Jan 12, 2015 Aug 15, 2017 Patent
Compounds, compositions and methods Aug 27, 2015 May 09, 2017 Patent
Substituted pyridazines as skeletal muscle modulators Jan 12, 2015 Mar 28, 2017 Patent
See all 67 patents